Joint Formulary & PAD

Fondaparinux sodium - VTE prevention post hip/knee replacement

You are here : Home > Formulary Search > Fondaparinux sodium - VTE prevention post hip/knee replacement

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Subcutaneous injection (sc)
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
SPC
Restrictions / Comments :
Important
Caution - potential for latex reactions in allergic patients.

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Fondaparinux sodium
Indication :
VTE prevention post hip/knee replacement
Group Name :
Keywords :
Brand Names Include :
Arixtra
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Committee Recommendations (0)

  • No records returned.

Other Indications

Below are listed other indications that Fondaparinux sodium is used to treat.

Other Drugs

Below are listed other drugs that are used to treat VTE prevention post hip/knee replacement.